19,259 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Acquired by Summit Global Investments

Summit Global Investments purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,259 shares of the exchange traded fund’s stock, valued at approximately $1,734,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Addison Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 27.4% during the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after buying an additional 115 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in SPDR S&P Biotech ETF by 0.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after purchasing an additional 148 shares in the last quarter. Invst LLC increased its stake in SPDR S&P Biotech ETF by 6.0% in the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after purchasing an additional 160 shares in the last quarter. Beech Hill Advisors Inc. increased its stake in SPDR S&P Biotech ETF by 2.5% in the fourth quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock valued at $599,000 after purchasing an additional 162 shares in the last quarter. Finally, Wealth Alliance increased its stake in SPDR S&P Biotech ETF by 4.4% in the fourth quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock valued at $368,000 after purchasing an additional 173 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $87.12 on Friday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company has a market capitalization of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99. The company has a 50 day moving average price of $89.59 and a two-hundred day moving average price of $94.35.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.